Coordinateur IT & OT (H/F)

Lyonbiopole; Auvergne-Rhône-Alpes; On-site; EUR 42,000 - 62,000; Full time

Job summary

Jubilant Biosys Ltd in France is seeking an IT & OT Support Coordinator to act as the local point of contact for the site. You will ensure the reliability, security, and performance of IT infrastructure and laboratory operational systems while collaborating with local teams, global IT colleagues and external partners.

This hands-on role covers IT infrastructure, networking, cybersecurity, laboratory systems, and vendor management to support scientific operations and compliance at the

Job description

We are looking for an IT & OT Supportcoordinator to become the key local point of contact for our France site.

In this role, you will ensure the reliability, security, and performance of IT infrastructure and laboratory operational systems while working closely with local teams, global IT colleagues, and external partners.

This is a hands-on position offering a broad scope of responsibilities across IT infrastructure, networking, cybersecurity, laboratory systems, and vendor management.

In March 2025, Jubilant Biosys Ltd, “Your CRDMO partner in science”, strengthened its European footprint through the strategic acquisition of an R&D Center of Excellence for Biologics in Saint-Julien-en-Genevois, France. This site has a rich legacy of advancing next-generation therapeutic biomolecules, with a strong focus on Biologics, including monoclonal antibodies (mAbs) and Antibody-Drug Conjugates (ADCs), and has successfully delivered multiple clinical candidates over the years. By integrating the deep scientific expertise of Jubilant Biosys France with the capabilities of our 1,200 scientists in India, we now offer a fully integrated portfolio spanning early-stage chemistry and biology research, DMPK, and end-to-end drug discovery. Our services extend through CDMO and API development, enabling seamless progression from concept to clinic. Our goal is to accelerate innovation and deliver cutting-edge solutions that address the complex challenges of modern drug development—ultimately improving patient outcomes worldwide.